Skip to main content
PHBI logo

PHBI · Pharmagreen Biotech Inc. · Financials

Track PHBI — free
$0.90 +0.00 (+0.00%) At close · Sep 18
Market Cap
$230.91M
Shares
691.35M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Net Income
-$875.51K +80.7%
FY2022 Net Income FY2018–FY2022
Operating Cash Flow
-$426.57K -107%
FY2022 Operating Cash Flow FY2018–FY2022

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2022 FY2021 FY2020 FY2019 FY2018
$3956 $7619
$30.02K $65.56K $79.42K $63.71K $99.08K $57.73K
$581.27K $1.1M $744.06K $485.76K $642.18K $748.72K
-$231.17K -$1.1M -$744.06K -$485.76K -$642.18K -$748.72K
$298.94K $3783
$80.37K $225.99K -$3.79M -$2M -$126.63K -$324.86K
-$2.48M -$768.81K
$0 $0 $0
-$500.71K -$875.51K -$4.53M -$2.48M -$767.54K -$1.07M
-$44.74K -$1274
shares 201.87K 146.85K 41.04K 37.03K 12.41K
shares 109.33K 163.02K 194.19K 182.43K 146.55K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1435181